| Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
|---|
| 09/18/2007 | US7271322 Soybean cultivar 900213 |
| 09/18/2007 | US7271321 Seed produced by crossing soybean cultivar 1000126 with another soybean cultivar; insect resistance, disease resistance, herbicide resistance |
| 09/18/2007 | US7271320 Soybean cultivar 901023 |
| 09/18/2007 | US7271318 Plant genes encoding pantothenate synthetase |
| 09/18/2007 | US7271317 Phytic acid biosynthetic enzymes |
| 09/18/2007 | US7271316 phosphatase stress-related protein (PHSRP) wherein expression of the nucleic acid sequence in the plant results in increased tolerance to environmental stress (drought, cold, oxidation) |
| 09/18/2007 | US7271314 Method for disrupting genes using tobacco retrotransposon |
| 09/18/2007 | US7271313 Presenilin-deficient mouse model of age-dependent neurodegeneration and cognitive loss |
| 09/18/2007 | US7271311 Mammalian model for diabetes |
| 09/18/2007 | US7271257 DNA which encodes the receptor, a transformed cell expressing the receptor, for producing the receptor, for identifying an agonist, antagonist, or allosteric modulator for glutamic acid |
| 09/18/2007 | US7271256 Method for producing circular or multimeric protein species in vivo or in vitro and related methods |
| 09/18/2007 | US7271255 Pichia methanolica secretory signal |
| 09/18/2007 | US7271254 Comprises nucleotide sequences coding myofibrillogenesis-inducing RNA (MIR) molecules for promoting cardiac muscle differentiation |
| 09/18/2007 | US7271251 Polyclonal and, or monoclonal antibodies; immuniglobulin immunization |
| 09/18/2007 | US7271250 Nucleotide sequences coding polypeptides for use in the diagnosis, prevention and treatment of cell proliferative disorders |
| 09/18/2007 | US7271246 Of given amino acid sequence; useful for promoting wound healing and stimulating platelet proliferation; can use in treating autoimmune diseases and cancer |
| 09/18/2007 | US7271244 for degrading or converting a cellulosic material |
| 09/18/2007 | US7271243 GENSET polynucleotides and polypeptides used as reagents in forensic analyses, as chromosome markers, as tissue/cell/organelle-specific markers, expression vectors production; screening/diagnosis assays for abnormal GENSET expression and/or biological activity; gene therapy; genomics |
| 09/18/2007 | US7271242 Cytotoxic cyplasin of the sea hare, aplysia punctata, cdna cloning and expression of bioreactive recombinants |
| 09/18/2007 | US7271156 Immunostimulatory nucleic acids |
| 09/18/2007 | US7271151 administering to effect phosphate metabolism in a patient; Metastatic-tumor Excreted Phosphaturic-Element (MERE) or "phosphatonin"; treating X-linked rickets and tumour osteomalacia for example |
| 09/18/2007 | US7271149 Comprises chimeric glucagon-like peptides-1 (GLP-1) for treating obesity and non-insulin dependent diabetes mellitus |
| 09/18/2007 | US7271148 Inhibition of cellular proteases |
| 09/18/2007 | US7271139 Lipolytic enzyme genes |
| 09/18/2007 | US7271005 Monitoring pseudomonas membrane permeability to aminoglycoside antibiotics; bactericidal membrane permeability increasing proteins |
| 09/18/2007 | US7271004 Transgenic expression of a phytochrome a gene |
| 09/18/2007 | US7271003 Expression vector comprising regulatory sequences which confer enhanced transcriptional activity when controlling expression of heterologous genes in plants; tissue engineering |
| 09/18/2007 | US7271002 Generating adeno-associated vector particles in insects; bioreactors and heterologous gene expression |
| 09/18/2007 | US7271001 Method for mitochondrial targeting of p53 |
| 09/18/2007 | US7271000 Providing cells containing double-stranded DNA, wherein such DNA comprising atleast I-Sce I meganucleases and selecting the cells in which double strand break has been induced; useful for mapping eukaryotic genomes; genetic engineering |
| 09/18/2007 | US7270999 Clock gene BMAL2 |
| 09/18/2007 | US7270997 Genetically engineered attenuated coxsackievirus virion for use as tool in immunotherapy |
| 09/18/2007 | US7270993 Transgenic cell comprising paracrystalline protein surface layer cleaving proteins for use as bioreactor: heterologous protein expression |
| 09/18/2007 | US7270991 Transgenic microorganism for use as bioreactor for expression of heterologous genes and proteins; antigen production and vaccine development |
| 09/18/2007 | US7270989 Method of producing non-bovine chymosin and use hereof |
| 09/18/2007 | US7270988 Identification and characterization of a novel alpha-amylase from maize endosperm |
| 09/18/2007 | US7270984 Polynucleotides encoding a 6-phosphogluconolactonase polypeptide from corynebacterium glutamicum |
| 09/18/2007 | US7270982 Using 16s ribosomal RNA as diagnostic tool in detection of campylobacter DNA sequences in biological fluids; diagnosing bacterial infection |
| 09/18/2007 | US7270981 Using recombinase-polymerase amplification to propagate target DNA without the use of thermocycling or thermophilic enzymes |
| 09/18/2007 | US7270979 DNA for expression of alpha 1-antitrypsin in methylotropic yeast |
| 09/18/2007 | US7270977 Polypeptides for identifying fungicidally active compounds |
| 09/18/2007 | US7270969 Methods of constructing and screening diverse expression libraries |
| 09/18/2007 | US7270968 PTH analogs for renal osteodystrophy and related uses |
| 09/18/2007 | US7270967 Nucleotide sequences coding preferential polypetpide for use in diagnosis and treatment of preferential genetic disorders |
| 09/18/2007 | US7270966 for drug screening agents for treatment and/or prevention of cystic fibrosis by receptor binding ligand; genetic engineering |
| 09/18/2007 | US7270964 Detection of antibodies to squalene in serum |
| 09/18/2007 | US7270963 Growth differentiation factor, lefty-2 |
| 09/18/2007 | US7270962 Screening for agonist or antagonist to axon outgrowth inhibitors for use in prevention and designing treatments for brain, stroke and spinal injured individuals |
| 09/18/2007 | US7270960 Diagnosis of ovarian carcinomas |
| 09/18/2007 | US7270957 Using ribosomal DNA to detect and quantify nitrosomonas in water supplies; biofiltration and sewage treatment; bioremediation; animal husbandry |
| 09/18/2007 | US7270955 Detecting modulators of a silencing mediator for retinoic acid receptor; relieving suppression of steroid/thyroid hormone receptor activity; GAL4 DNA binding domains |
| 09/18/2007 | US7270953 Compositions for isolating and/or stabilising nucleic acids in biological material |
| 09/18/2007 | US7270950 Nucleic acid-protein fusions and methods of making and selecting fusions |
| 09/18/2007 | US7270827 For prophylaxis and therapy of microbial infection and eliciting a protective immune response |
| 09/18/2007 | US7270825 Production of a parvovirus vaccine in plants as viral coat protein fusions |
| 09/18/2007 | US7270821 Hepatitis B core antigen fusion proteins |
| 09/18/2007 | US7270820 Comprise viral amino acid sequences for use in vaccine preparation and prevention of viral infection |
| 09/18/2007 | US7270817 ACPL antibodies and methods of use thereof |
| 09/18/2007 | US7270816 Interleukins; fusion proteins; solid phase synthesis; kits |
| 09/18/2007 | US7270815 2-O sulfatase compositions and related methods |
| 09/18/2007 | US7270811 Recombinant replication-defective adenovirus serotypes 11, 25, 34, 35, 48 and 49 as gene delivery vehicles for gene therapy; reduced drug resistance, increased effectiveness of vaccination |
| 09/18/2007 | US7270380 Inbred maize line PH7JB |
| 09/18/2007 | CA2436618C Thermal cycler for automatic performance of the polymerase chain reaction with close temperature control |
| 09/18/2007 | CA2426543C Anti-angiogenic polypeptides |
| 09/18/2007 | CA2418267C Method of screening ptp zeta activity promoter or inhibitor |
| 09/18/2007 | CA2415494C Method of detection by enhancement of silver staining |
| 09/18/2007 | CA2413916C Dna/rna-embedding medium and method of use |
| 09/18/2007 | CA2404248C Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 09/18/2007 | CA2359775C Avian pluripotent embryonic germ cell line |
| 09/18/2007 | CA2299586C Human glial cell line-derived neurotrophic factor promoters, vectors containing same, and methods of screening compounds therewith |
| 09/18/2007 | CA2276460C Novel method for testing the differentiation status in pancreatic cells of a mammal |
| 09/18/2007 | CA2259420C Erythromycins and process for their preparation |
| 09/18/2007 | CA2185541C Cytotoxic t-cell epitopes |
| 09/18/2007 | CA2137161C Nucleic acids and methods of use thereof for controlling viral pathogens |
| 09/18/2007 | CA2102043C Mutant aox2 promoter, vector carrying same, transformant, and production of heterologous protein |
| 09/16/2007 | CA2539902A1 Method of enhancing degradation of chitin |
| 09/15/2007 | CA2581848A1 A process for immobilizing cells on a resin |
| 09/15/2007 | CA2579507A1 Novel isolated and purified strains of chikungunya virus and polynucleotides and polypeptides sequences, diagnostic and immunogenical uses thereof |
| 09/15/2007 | CA2545597A1 Novel isolated and purified strains of chikungunya virus and polynucleotides and polypeptides sequences, diagnostic and immunogenical uses thereof |
| 09/13/2007 | WO2007103988A2 Compositions and methods for detection and treatment of human herpesvirus (hhv)-6 |
| 09/13/2007 | WO2007103956A2 Compositions and methods for increasing plant tolerance to high population density |
| 09/13/2007 | WO2007103876A2 Cancer therapeutic |
| 09/13/2007 | WO2007103785A2 Plant-derived protein compositions |
| 09/13/2007 | WO2007103738A2 Compositions related to the quantitative trait locus 6 (qtl6) in maize and methods of use |
| 09/13/2007 | WO2007103549A2 Complement binding aptamers and anti-c5 agents useful in the treatment of ocular disorders |
| 09/13/2007 | WO2007103448A2 Rifaximin anti-rectal dysfunction preparation |
| 09/13/2007 | WO2007103382A2 Plant-specific genetic elements and transfer cassettes for plant transformation |
| 09/13/2007 | WO2007103307A2 Site-specific incorporation of amino acids into molecules |
| 09/13/2007 | WO2007103290A2 Materials and methods directed to asparagine synthetase and asparaginase therapies |
| 09/13/2007 | WO2007103225A2 Engineered listeria and methods of use thereof |
| 09/13/2007 | WO2007103201A2 Cellular delivery of sirna |
| 09/13/2007 | WO2007102936A2 Polynucleotides for production of farnesyl dibenzodiazepinones |
| 09/13/2007 | WO2007102690A1 Vector including the codon-optimized dna cassette for producing secretory recombinant dodecamer trail |
| 09/13/2007 | WO2007102618A1 Nucleic acid cleaving agent |
| 09/13/2007 | WO2007102581A1 2'-hydroxyl-modified ribonucleoside derivative |
| 09/13/2007 | WO2007102578A1 Method of designing base sequence |
| 09/13/2007 | WO2007102572A1 Inhibitor for cellular aging |
| 09/13/2007 | WO2007102516A1 Double-knockout non-human model animal for rna interference |
| 09/13/2007 | WO2007102507A1 Protein phosphorylation indicator |
| 09/13/2007 | WO2007102442A1 Monoclonal antibody, hybridoma, and method for quantification of lipopolysaccharide |